Yara International Past Earnings Performance
Past criteria checks 0/6
Yara International has been growing earnings at an average annual rate of 15.5%, while the Chemicals industry saw earnings growing at 11.8% annually. Revenues have been growing at an average rate of 10.7% per year.
Key information
15.5%
Earnings growth rate
16.7%
EPS growth rate
| Chemicals Industry Growth | 12.4% |
| Revenue growth rate | 10.7% |
| Return on equity | -0.5% |
| Net Margin | -0.3% |
| Next Earnings Update | 19 Jul 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Yara International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 14,595 | -38 | 1,483 | 0 |
| 31 Dec 23 | 15,431 | 48 | 1,440 | 0 |
| 30 Sep 23 | 17,363 | 573 | 1,384 | 0 |
| 30 Jun 23 | 19,661 | 973 | 1,341 | 0 |
| 31 Mar 23 | 22,111 | 1,937 | 1,326 | 0 |
| 31 Dec 22 | 23,902 | 2,777 | 1,335 | 0 |
| 30 Sep 22 | 23,551 | 2,048 | 1,334 | 0 |
| 30 Jun 22 | 21,898 | 1,506 | 1,340 | 0 |
| 31 Mar 22 | 19,412 | 1,380 | 1,331 | 0 |
| 31 Dec 21 | 16,616 | 449 | 1,314 | 0 |
| 30 Sep 21 | 14,442 | 655 | 1,287 | 0 |
| 30 Jun 21 | 12,932 | 1,136 | 1,269 | 0 |
| 31 Mar 21 | 11,890 | 821 | 1,219 | 0 |
| 31 Dec 20 | 11,591 | 691 | 1,186 | 0 |
| 30 Sep 20 | 11,684 | 645 | 1,182 | 0 |
| 30 Jun 20 | 12,176 | 379 | 1,179 | 0 |
| 31 Mar 20 | 12,699 | 386 | 1,208 | 0 |
| 31 Dec 19 | 12,858 | 599 | 1,225 | 0 |
| 30 Sep 19 | 13,254 | 556 | 1,228 | 0 |
| 30 Jun 19 | 13,281 | 581 | 1,243 | 0 |
| 31 Mar 19 | 13,081 | 139 | 1,260 | 0 |
| 31 Dec 18 | 12,928 | 159 | 1,268 | 0 |
| 30 Sep 18 | 12,439 | 106 | 1,370 | 0 |
| 30 Jun 18 | 11,941 | 98 | 1,376 | 0 |
| 31 Mar 18 | 11,501 | 392 | 1,322 | 0 |
| 31 Dec 17 | 11,358 | 477 | 1,282 | 0 |
| 30 Sep 17 | 11,230 | 331 | 1,340 | 0 |
| 30 Jun 17 | 10,936 | 341 | 1,264 | 0 |
| 31 Mar 17 | 10,892 | 616 | 1,230 | 0 |
| 31 Dec 16 | 11,029 | 736 | 1,209 | 0 |
| 30 Sep 16 | 12,328 | 891 | 1,300 | 0 |
| 30 Jun 16 | 12,162 | 1,231 | 1,231 | 0 |
| 31 Mar 16 | 12,736 | 1,229 | 1,241 | 0 |
| 31 Dec 15 | 12,203 | 913 | 1,133 | 0 |
| 30 Sep 15 | 12,740 | 1,114 | 1,100 | 0 |
| 30 Jun 15 | 13,418 | 916 | 1,140 | 0 |
| 31 Mar 15 | 12,566 | 817 | 1,061 | 0 |
| 31 Dec 14 | 12,744 | 1,019 | 1,093 | 0 |
| 30 Sep 14 | 13,950 | 907 | 1,183 | 0 |
| 30 Jun 14 | 14,028 | 928 | 1,204 | 0 |
| 31 Mar 14 | 14,339 | 881 | 1,190 | 0 |
| 31 Dec 13 | 13,960 | 948 | 1,133 | 0 |
| 30 Sep 13 | 14,063 | 1,305 | 891 | 0 |
| 30 Jun 13 | 13,932 | 1,457 | 861 | 0 |
Quality Earnings: IU2 is currently unprofitable.
Growing Profit Margin: IU2 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IU2 is unprofitable, but has reduced losses over the past 5 years at a rate of 15.5% per year.
Accelerating Growth: Unable to compare IU2's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IU2 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-19.4%).
Return on Equity
High ROE: IU2 has a negative Return on Equity (-0.47%), as it is currently unprofitable.